| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD008458 | Stability Study Protocol for 0.1% Estradiol Type A Medicated Article (Estraqua?) | 000 | 1 | FDA | 12/17/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $440,296 ) |
| | 2025 | 2025 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD008456 | Environmental Assessment of Estraqua? (Estradiol Type A Medical Article) for American Eels in Recirculating Aquaculture Systems (RAS) | 000 | 1 | FDA | 9/19/2025 | $190,296 |
| | 2025 | 2025 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD008458 | Stability Study Protocol for 0.1% Estradiol Type A Medicated Article (Estraqua?) | 000 | 1 | FDA | 9/19/2025 | $250,000 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 001 | 2 | FDA | 11/3/2020 | $0 |
| | 2021 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 001 | 2 | FDA | 11/3/2020 | $0 |
| | 2021 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 001 | 2 | FDA | 11/3/2020 | $0 |
| | 2021 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 000 | 2 | FDA | 11/3/2020 | $0 |
| | 2021 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 000 | 2 | FDA | 11/3/2020 | $0 |
| | 2021 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 000 | 2 | FDA | 11/3/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $112,500 ) |
| | 2020 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 000 | 2 | FDA | 3/31/2020 | $37,500 |
| | 2020 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 000 | 2 | FDA | 3/31/2020 | $37,500 |
| | 2020 | 2020 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 000 | 2 | FDA | 3/31/2020 | $37,500 |
|
| Issue Date FY: 2019 ( Subtotal = $449,000 ) |
| | 2019 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 001 | 2 | FDA | 6/28/2019 | $149,000 |
| | 2019 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 001 | 2 | FDA | 6/28/2019 | $150,000 |
| | 2019 | 2019 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 001 | 2 | FDA | 6/28/2019 | $150,000 |
| | 2019 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 000 | 1 | FDA | 2/12/2019 | $0 |
| | 2019 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 000 | 1 | FDA | 2/12/2019 | $0 |
| | 2019 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 000 | 1 | FDA | 2/12/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $450,000 ) |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 000 | 1 | FDA | 7/23/2018 | $150,000 |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 001 | 1 | FDA | 8/10/2018 | $0 |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 001 | 1 | FDA | 8/10/2018 | $0 |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006321 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain, Protocol No. NE-002 | 001 | 1 | FDA | 8/10/2018 | $0 |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006319 | Pivotal Study to Demonstrate the Safety of Estradiol Administered in Feed to American Eels (Anguilla rostrata), Protocol No. NE-003 | 000 | 1 | FDA | 7/23/2018 | $150,000 |
| | 2018 | 2018 | NOVAEEL INC | 2161 ARMCRESCENT EAST DR | HALIFAX | NS | B3L 3C8 | | CAN | R01FD006322 | Pivotal Study to Demonstrate the Effectiveness of Estradiol Administered in Feed to American Eels (Anguilla rostrata) for Increased Rate of Weight Gain Protocol NE-001 | 000 | 1 | FDA | 7/23/2018 | $150,000 |
|
|
Tuesday, January 6, 2026
1/6/2026
